Surbhi Sarna
InvestorFounderBoard Trustee at Astia · Board director at AOA Dx · Founder at Nvision Medical · CEO and Founder at Collate
San Francisco, California, United States
FoundedCollateNvision Medical
Find your path to Surbhi
2,388 people in our graph share verified history with Surbhi — schools, employers, funds. One of them is your warm intro.
About
Surbhi Sarna is CEO and founder of Collate, a company that develops GxP-compliant and custom AI workflows for global life science companies and has raised $125M. She previously founded the life science company nVision, which Boston Scientific acquired in 2018 for $275M, and spent 4.5 years as a General Partner at Y Combinator. Sarna serves on public and private company boards and authored Without a Doubt, published by Simon and Schuster in 2023.
Board director at AOA DxYC S21
Intro paths
AOA Dx went through Y Combinator (Summer 2021) — Surbhi sits on its board, so any YC alum in your network can reach them through the company's founders.
AOA Dx's group partner at YC was Jared Friedman, YC Group Partner — the partner who ran AOA Dx's batch and knows the company first-hand. YC profile ↗
In turn, Surbhi can intro founders to AOA Dx's investors below.
AOA Dx's investors · 26
Co-founders at AOA Dx



Founder at Nvision Medical
Intro paths
In turn, Surbhi can intro founders to Nvision Medical's investors below.
Nvision Medical's investors · 1
CEO and Founder at Collate
Intro paths
In turn, Surbhi can intro founders to Collate's investors below.
Collate's investors · 3
Co-founders at Collate


Experience
- CollateCEO and Foundercurrent2025 — presentSan Francisco, California, United States
- Penumbra, Inc.Board Directorcurrent2019 — present
- Draper UniversityBoard Membercurrent2018 — presentSan Mateo County, California, United States
- AstiaBoard Trusteecurrent2020 — present
- The Harker SchoolBoard Trustee2020 — 2026
- Y CombinatorGeneral Partner2021 — 2025
- Y CombinatorVisiting Partner2020 — 2021
- Biora TherapeuticsBoard Director2021 — 2023San Diego, California, United States
- Boston ScientificPresident, nVision Medical2018 — 2020Boston, Massachusetts, United States
- nVision MedicalCEO & Founder2012 — 2018
- Cardiovascular Device Start upProduct Development Engineer2008 — 2011
- AbbottQuality Engineer2007 — 2008
- AbbottR&D Scientist/Engineer Intern2006
- Stanford University School of MedicineClinical Scientist Intern2004 — 2005
Skills & more
+9 more
Design for ManufacturingBiotechnologyProduct DevelopmentQuality SystemCommercializationGMPMarket DevelopmentProduct LaunchSolidworksFrom Surbhi's professional profile.
Colleagues at Astia
Frequently asked questions
- Who is Surbhi Sarna?
- Surbhi Sarna is CEO and founder of Collate, a company that develops GxP-compliant and custom AI workflows for global life science companies and has raised $125M. She previously founded the life science company nVision, which Boston Scientific acquired in 2018 for $275M, and spent 4.5 years as a General Partner at Y Combinator. Sarna serves on public and private company boards and authored Without a Doubt, published by Simon and Schuster in 2023.
- Where does Surbhi Sarna work?
- Surbhi Sarna is CEO and Founder of Collate and Board Trustee at Astia and Board director at AOA Dx and Co-founder at Nvision Medical.
- What companies did Surbhi Sarna found?
- Surbhi Sarna founded Collate, Nvision Medical.
- Where did Surbhi Sarna go to school?
- Surbhi Sarna studied at University of California, Berkeley (MCB & BioE); The Harker School.
Founder mafias
Y Combinator mafia10,230
Also came through, then founded or led a company.
+ 10,223 more
The Harker School mafia35
Also came through, then founded or led a company.
+ 28 more
Astia mafia4
Also came through, then founded or led a company.
Same school
Also attended University of California, Berkeley2,000
+ 1,994 more
Shared employers
Also worked at Collate10
+ 4 more
Also worked at The Harker School5
Also worked at Y Combinator427
+ 421 more
Also worked at Boston Scientific157
+ 151 more


































































